Feedback / Questions
BH-30643 - BlossomHill Therap
https://www.globenewswire.com/news-release/2025/08/22/3137796/0/en/BlossomHill-Therapeutics-Announces-First-Patient-Dosed-in-Expansion-Cohorts-of-the-Phase-1-2-SOLARA-Trial-Evaluating-BH-30643-in-Advanced-EGFR-mutant-Non-Small-Cell-Lung-Cancer.html
Aug 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next